The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population

被引：3

作者：

Alkattan, Abdullah ^{[1
,2
]}

Almutairi, Yousef ^{[2
]}

Alsalameen, Eman ^{[3
]}

Alkhalifah, Ahmed ^{[4
]}

Alghanim, Fatimah ^{[5
]}

机构：

[1] King Faisal Univ, Dept Biomed Sci, Coll Vet Med, Al Hufuf 31982, Al Ahsa, Saudi Arabia

[2] Minist Hlth, Dept Res & Dev, Chron Dis Prevent Ctr, Riyadh, Saudi Arabia

[3] Med City King Saud Univ, King Khaled Univ Hosp, Dept Pharm, Riyadh, Saudi Arabia

[4] Alhaya Med Co, Dept Sales, Fresenius Kabi, Dammam, Saudi Arabia

[5] Imam Abdulrahman bin Faisal Univ, Dept Gen Med, Fac Med, Dammam, Saudi Arabia

来源：

INDIAN JOURNAL OF PHARMACOLOGY | 2021年 / 53卷 / 01期

关键词：

GENETIC-POLYMORPHISM; PON1;

D O I：

10.4103/ijp.IJP_690_20

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：85 / 87

页数：3

共 11 条

[1]

Abid L., 2013, World J. Cardiovasc. Dis., P4, DOI [10.4236/, 10.4236/wjcd.2013.31002, DOI 10.4236/WJCD.2013.31002]

[2]

Ahmad M., 2018, GLOBAL J HLTH SCI, V10, P1, DOI [10.5539/gjhs.v10n7p36, DOI 10.5539/GJHS.V10N7P36]

[3] CYP2C19 Genetic Polymorphism in Saudi Arabians [J].

Al-Jenoobi, Fahad I. ;

Alkharfy, Khalid M. ;

Alghamdi, Amal M. ;

Bagulb, Khawla M. ;

Al-Mohizea, Abdullah M. ;

Al-Muhsen, Saleh ;

Halwani, Rabih ;

Parvez, Mohammad Khalid ;

Al-Dosari, Mohammed S. .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (01) :50-54

[4] Pharmacogenetics of CYP2C19 genetic polymorphism on clopidogrel response in patients with ischemic stroke from Saudi Arabia [J].

Alhazzani, Adel A. ;

Munisamy, Murali ;

Karunakaran, Gauthaman .

NEUROSCIENCES, 2017, 22 (01) :31-37

[5] P2Y12 platelet inhibition in clinical practice [J].

Damman, Peter ;

Woudstra, Pier ;

Kuijt, Wichert J. ;

de Winter, Robbert J. ;

James, Stefan K. .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 33 (02) :143-153

[6] Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function [J].

Frelinger, Andrew L., III ;

Bhatt, Deepak L. ;

Lee, Ronald D. ;

Mulford, Darcy J. ;

Wu, Jingtao ;

Nudurupati, Sai ;

Nigam, Anu ;

Lampa, Michael ;

Brooks, Julie K. ;

Barnard, Marc R. ;

Michelson, Alan D. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (08) :872-879

[7] Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS Study [J].

Gradoli, Josep ;

Vidal, Veronica ;

Brady, Adrian J. B. ;

Facila, Lorenzo .

EUROPEAN CARDIOLOGY REVIEW, 2018, 13 (02) :115-118

[8]

Khalaf Hassan, 2016, Drug Metab Lett, V10, P65

[9] Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population [J].

Khalil, B. M. ;

Shahin, M. H. ;

Solayman, M. H. M. ;

Langaee, T. ;

Schaalan, M. F. ;

Gong, Y. ;

Hammad, L. N. ;

Al-Mesallamy, H. O. ;

Hamdy, N. M. ;

El-Hammady, W. A. ;

Johnson, J. A. .

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2016, 9 (01) :23-28

[10] Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels [J].

Malaguarnera, Giulia ;

Latteri, Saverio ;

Catania, Vito Emanuele ;

Malaguarnera, Michele .

JOURNAL OF THORACIC DISEASE, 2017, 9 (08) :2332-2336

← 1 2 →